Accent Therapeutics Announces $75 Million Series C Financing to

/PRNewswire/ -- Accent Therapeutics, a biopharmaceutical company pioneering a new class of small molecule precision cancer therapies, today announced the

Scene Health Secures $17.7 Million Series B Financing Led by ABS Capital Partners

Biotech, Pharmaceutical and Clinical Research News

Carmot gets $150 million to finance its obesity pipeline

ADC Therapeutics closes upsized IPO of over $267.6 million

Orgenesis Tackles Cell Therapy Costs, Barriers With Decentralized Model

Accent secures funding to advance therapies for cancer

How Washington's favorite cancer fighter helps himself - POLITICO

The Column Group on LinkedIn: ORIC Pharmaceuticals Announces $125 Million Private Placement Financing

Jose Feliciano Honored By Miami Children's Health Foundation At 10th Anniversary Diamond Ball On Oct. 29

Accent secures funding to advance therapies for cancer

Droia Ventures – Investing in Impact – Life Science

Releases - Big4Bio